购物车
- 全部删除
- 您的购物车当前为空
Ciraparantag acetate 是一种抗凝逆转剂,是一种小分子,专门设计用于通过电荷-电荷相互作用与普通肝素和低分子量肝素非共价结合。它显示出与直接口服抗凝剂 (DOAC) 相似的结合特性。
Ciraparantag acetate 是一种抗凝逆转剂,是一种小分子,专门设计用于通过电荷-电荷相互作用与普通肝素和低分子量肝素非共价结合。它显示出与直接口服抗凝剂 (DOAC) 相似的结合特性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 412 | 现货 | |
5 mg | ¥ 993 | 现货 | |
10 mg | ¥ 1,490 | 现货 | |
25 mg | ¥ 3,150 | 现货 | |
50 mg | ¥ 4,560 | 现货 | |
100 mg | ¥ 6,390 | 现货 | |
200 mg | ¥ 8,620 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,250 | 现货 |
产品描述 | Ciraparantag acetate, an anticoagulant reversal agent, is a small molecule specifically designed to bind noncovalently by charge-charge interaction to unfractionated heparin and low-molecular-weight heparin. It shows binding characteristics that are similar to those of direct oral anticoagulants (DOACs). |
别名 | Ciraparantag acetate(1438492-26-2 Free base) |
分子量 | 572.75 |
分子式 | C24H52N12O4 |
CAS No. | 1644388-83-9 |
存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 65 mg/ml (113.49 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.